NRX.V · NurExone Biologic Inc.
Canada · RS rating 39 · As of 2026-10-14
| Price | 0.58 CAD |
|---|---|
| 1-day change | -3.3% |
| RS rating (overall / 1M / 3M / 12M) | 39 / 36 / 76 / 16 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 20 / 15 / 6 |
| Industry group (rank) | Medical-Biomed/Biotech (54) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | – |
| Distance from 52-week high | +40.8% |
| Market cap (USD) | $38.8M |